Nuzenio

Relmada Therapeutics Appoints

Relmada Therapeutics Appoints news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Piper Sandler Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD) - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 15:30:00 GMTRelmada Therapeutics Appoints Bipin Dalmia as Chief Business Officer to Advance NDV-01 and Corporate Growth - MoomooMoomoo · Sat, 01 Aug 2026 13:07:52 GMTRelmada Therapeutics Appoints New Chief Business Officer - The Globe and MailThe Globe and Mail · Wed, 29 Jul 2026 07:00:00 GMTRelmada hires executive with U.S. bladder cancer gene therapy experience - Stock TitanStock Titan · Tue, 28 Jul 2026 12:30:00 GMT

Timeline

Sat, 08 Aug 2026 15:30:00 GMTPiper Sandler Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD) - The Globe and Mail
Sat, 01 Aug 2026 13:07:52 GMTRelmada Therapeutics Appoints Bipin Dalmia as Chief Business Officer to Advance NDV-01 and Corporate Growth - Moomoo
Wed, 29 Jul 2026 07:00:00 GMTRelmada Therapeutics Appoints New Chief Business Officer - The Globe and Mail
Tue, 28 Jul 2026 12:30:00 GMTRelmada hires executive with U.S. bladder cancer gene therapy experience - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Relmada Therapeutics Appoints.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.